The global burden and death toll of fungi has substantially climbed over the past decade, new research finds. The study estimates that fungal infections help kill nearly 4 million people annually—almost double the amount estimated by similar research in 2012. Co-infections like HIV and tuberculosis, a lack of speedy and reliable diagnostic testing, and growing antifungal resistance are thought to be major contributors to these deaths.
Following FDA approval earlier this year, Rezzayo (Rezafungin acetate) became the initial drug authorized for candidemia and invasive candidiasis treatment in over a decade.